Anna Sandstrom
Pediatric Endocrinology · Oxnard, CANPI 1043382856
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations.
Across 174 payments — averaging $27.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$480
- Tandem Diabetes Care, Inc.$378
- Insulet Corporation$371
- Azurity Pharmaceuticals, Inc.$301
- Medtronic$281
- Neurocrine Biosciences, Inc.$273
- plus $3K from 25 others
What the payments were for
- Food & beverage$4,78699%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 15 | $480 |
| Tandem Diabetes Care, Inc. | 5 | $378 |
| Insulet Corporation | 13 | $371 |
| Azurity Pharmaceuticals, Inc. | 14 | $301 |
| Medtronic(2 entities) | 5 | $281 |
| Neurocrine Biosciences, Inc. | 5 | $273 |
| Dexcom, Inc. | 12 | $271 |
| Tolmar, Inc. | 14 | $270 |
| Arbor Pharmaceuticals, Inc. | 10 | $252 |
| Xeris Pharmaceuticals, Inc. | 11 | $221 |
| Novo Nordisk | 8 | $209 |
| Sequel Med Tech, LLC | 3 | $202 |
| Abbott | 9 | $177 |
| Sanofi-aventis U.S. LLC | 3 | $176 |
| Amphastar Pharmaceuticals, Inc. | 9 | $151 |
| AstraZeneca | 6 | $134 |
| Pfizer | 6 | $130 |
| Tolmar Pharmaceuticals, Inc. | 4 | $82 |
| Rhythm Pharmaceuticals, Inc. | 3 | $73 |
| Eton Pharmaceuticals, Inc. | 2 | $63 |
| Zealand Pharma US, Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| AbbVie | 2 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $37 |
| Soleno Therapeutics, Inc. | 1 | $34 |
| Intuity Medical Inc | 2 | $33 |
| Companion Medical, Inc. | 2 | $29 |
| BETA Bionics, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $19 |
| Vistapharm, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$249
- CRENESSITY$138
- Omnipod$134
- TZIELD$122
How this compares
$4,833 in reported general payments places this provider in the 75th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Oxnard
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
- Stephen GitelmanSan Francisco$105K
- David MaahsStanford$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.